ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 77810 Naphtho[1,2-b]quinolizinium, 9-methyl-, bromide 0.0382675857669585 0.050146603
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0388857481216103 0.32419438
NSC 630375 2H-1-Benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- 0.0388857481216103 -0.27785162
NSC 681105 Acetic acid, [1,4,7,10-tetraazacyclododecane-1,7-diyl]bis 0.0388857481216103 0.31138918
NSC 682995 5,8-Quinolinedione, 2-methyl- 0.0388857481216103 0.28723366
NSC 684405 1-(4'-Phthalimidopropyl-carbonyl)-5-fluorouracil 0.0388857481216103 0.36469879
NSC 691250 Null 0.0388857481216103 0.58744296
NSC 81052 Streptonigrin analog (MeO-N3) 0.0388857481216103 0.32834222
NSC 134228 .alpha.-Toluenethiol, .alpha.-(nitromethyl)-,acetate (ester) (8CI) 0.0420893367628879 0.10059644
NSC 140380 Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) 0.0420893367628879 0.40628136
Total:122  Current:100    [First] [Prev] [Next] [Last]